Capgemini Invent was approached by a client, that was preparing for a drug launch, to monitor the patient journey from the referral phase through the dispensing phase.
Our specialty channel insights platform for pharmaceutical manufacturers was deployed to support the launch. The platform quickly identified and removed potential barriers for getting patients on therapy. The Capgemini Invent team monitored launch performance and provided visibility into the specialty distribution channel for the client. Post launch, our analytics supported real time decision-making regarding bridge and other patient support programs.
Utilizing the services of the specialty channel insights platform, the drug launched with great commercial success. The platform played a key role in assisting with critical strategic decision making at the time of the launch. As a result of our solution’s proven success, the client has now added seven other brands to the platform.